Cns Pharmaceuticals Inc (CNSP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,718 | -3,152 | -14,495 | -11,241 | -7,427 |
| Depreciation Amortization | 7 | 3 | 13 | 10 | 6 |
| Accounts payable and accrued liabilities | -665 | -666 | 1,035 | 515 | -54 |
| Other Working Capital | -354 | -266 | -780 | -477 | -1,785 |
| Other Operating Activity | 1,290 | 1,002 | 689 | 892 | 954 |
| Operating Cash Flow | $-6,440 | $-3,077 | $-13,538 | $-10,302 | $-8,306 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -3 | N/A | -6 | -4 | -4 |
| Investing Cash Flow | $-3 | $N/A | $-6 | $-4 | $-4 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 10,628 | 10,628 | 4,987 | 4,987 | 1,418 |
| Other Financing Activity | -231 | -115 | -478 | -395 | -262 |
| Financing Cash Flow | $10,397 | $10,513 | $4,509 | $4,592 | $1,156 |
| Beginning Cash Position | 5,005 | 5,005 | 14,040 | 14,040 | 14,040 |
| End Cash Position | 8,959 | 12,441 | 5,005 | 8,326 | 6,886 |
| Net Cash Flow | $3,954 | $7,436 | $-9,035 | $-5,713 | $-7,154 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,440 | -3,077 | -13,538 | -10,302 | -8,306 |
| Capital Expenditure | -3 | N/A | -6 | -4 | -4 |
| Free Cash Flow | -6,443 | -3,077 | -13,544 | -10,305 | -8,310 |